Clinical Trials Logo

Clinical Trial Details — Status: Recruiting

Administrative data

NCT number NCT04167059
Other study ID # RGS0000003371
Secondary ID
Status Recruiting
Phase N/A
First received
Last updated
Start date January 1, 2020
Est. completion date September 1, 2021

Study information

Verified date February 2020
Source Telethon Kids Institute
Contact Jenny Downs, PhD
Phone +61 8 6319 1763
Email Jenny.Downs@telethonkids.org.au
Is FDA regulated No
Health authority
Study type Interventional

Clinical Trial Summary

This study will recruit families with a daughter with Rett syndrome living in either Australia, Denmark or Israel, and thereafter deliver individually designed participation programs using telehealth strategies. We will evaluate the effectiveness of the programs on reducing sedentary behaviours, increasing physical activity and increasing quality of life.


Description:

This project will implement two intertwined strategies that will build the capacity of the carer, clinical and therapy communities to support physical activity in Rett syndrome. Individuals with Rett syndrome experience difficulties with movement and this can make it difficult to participate in regular physical activity. Individuals with Rett syndrome need support to participate in physical activities and it is important to work with primary caregivers when developing strategies to support physical activity. We will conduct a clinical trial that tests the effectiveness of working with primary caregivers to develop strategies suitable to their lives that aim to increase participation in physical activity in the individual with Rett syndrome whom they support. We will use a clinical trial design and work with primary caregivers using Telehealth. We will test whether this approach decreases sedentary time and increases physical activity. We will also test if there are changes in the sleep, behaviour and quality of life. We aim to recruit 60 families for this study, 26 of whom will live in Australia. Data from the three sites will be pooled for a stronger analysis. We acknowledge that physical activity can be associated with a fall and therefore our program will be developed with the primary caregiver to be suitable for their lives and capacity to provide support. However, by practicing more activity, the individuals with Rett syndrome could be stronger and risks of falling could be reduced. The risks for the individual with Rett syndrome are therefore low. To let the Rett syndrome community know our results, we will then develop an online resource documenting the physical activity program and the evidence available to support it, and this will be freely available to families, carers and therapists wherever they live in the world.


Recruitment information / eligibility

Status Recruiting
Enrollment 60
Est. completion date September 1, 2021
Est. primary completion date September 1, 2020
Accepts healthy volunteers No
Gender All
Age group 5 Years to 40 Years
Eligibility Inclusion Criteria:

- Genetically confirmed Rett syndrome

- Able to stand (with or without assistance)

- Live in Australia, Denmark or Israel

Exclusion Criteria:

- Individuals who have had spinal fusion over the previous 12 months

- Individuals who have had lower extremity orthopaedic surgery over the previous 6 months

Study Design


Related Conditions & MeSH terms


Intervention

Behavioral:
Telehealth-delivered participation strategies to increase physical activity
Therapists and primary caregivers will meet online on 6 occasions at fortnightly intervals over a 12 week period. Sessions will enable the development of strategies that will aim to increase the amount the participant stands and walks. Throughout, the therapists and primary caregivers will discuss physical activity needs, determine relevant activities, modify the program as necessary and plan additional goals.

Locations

Country Name City State
Denmark Center for Rett Syndrom, Rigshospitalet Copenhagen
Israel Ari'el University Ari'el

Sponsors (4)

Lead Sponsor Collaborator
Telethon Kids Institute Ariel University, Rigshospitalet, Denmark, University of Haifa

Countries where clinical trial is conducted

Denmark,  Israel, 

Outcome

Type Measure Description Time frame Safety issue
Primary Average daily uptime (%) Percentage of time spent active (uptime) over total awake time, measured with an ActivPAL Average over 4 days, data capture at baseline, after 12 weeks and after 24 weeks
Primary Average daily step count Number of daily steps measured by Stepwatch Activity Monitor Average over 4 days, data capture at baseline, after 12 weeks and after 24 weeks
Secondary Sleep quality Sleep Disturbance Scale for Children. Parent caregiver recall over previous month, data capture at baseline, after 12 weeks and after 24 weeks
Secondary Behaviour Rett Syndrome Behaviour Scale Parent caregiver recall over previous month, data capture at baseline, after 12 weeks and after 24 weeks
Secondary Child Quality of Life Quality of Life Inventory-Disability (QI-Disability) Parent caregiver recall over previous month, data capture at baseline, after 12 weeks and after 24 weeks
See also
  Status Clinical Trial Phase
Completed NCT04988867 - An Open-Label Study of Trofinetide for the Treatment of Girls Two to Five Years of Age Who Have Rett Syndrome Phase 2/Phase 3
Recruiting NCT00069550 - Independent Studies of Dextromethorphan and of Donepezil Hydrochloride for Rett Syndrome Phase 3
Enrolling by invitation NCT06139172 - Promoting Prosocial Behavior in Syndromic Intellectual and Developmental Disabilities N/A
Not yet recruiting NCT04014985 - Patients With RETT Syndrome N/A
Not yet recruiting NCT04041713 - A Pilot Study of an Antioxidant Cocktail vs. Placebo in the Treatment of Children and Adolescents With Rett Syndrome Phase 2
Completed NCT02705677 - Biobanking of Rett Syndrome and Related Disorders
Terminated NCT02790034 - Evaluation of the Efficacy, Safety, and Tolerability of Sarizotan in Rett Syndrome With Respiratory Symptoms Phase 2/Phase 3
Enrolling by invitation NCT03655223 - Early Check: Expanded Screening in Newborns
Recruiting NCT05932589 - Neurophysiologic Biomarkers in Rett Syndrome
Recruiting NCT04463316 - GROWing Up With Rare GENEtic Syndromes
Completed NCT04776746 - Open-Label Extension Study of Trofinetide for Rett Syndrome Phase 3
Completed NCT04181723 - Study of Trofinetide for the Treatment of Girls and Women With Rett Syndrome (LAVENDERâ„¢) Phase 3
Enrolling by invitation NCT03836300 - Parent and Infant Inter(X)Action Intervention (PIXI) N/A
Completed NCT04514549 - ASSESSING EMERALD AND MC10 BIOSTAMP nPOINT BIOSENSORS FOR RETT SYNDROME
Terminated NCT02562820 - An Exploratory Trial of Ketamine for the Treatment of Rett Syndrome Phase 1
Completed NCT02738281 - Natural History of Rett Syndrome & Related Disorders
Completed NCT05687214 - Osteopathic Manipulative Treatment for Constipation in People With Rett Syndrome N/A
Recruiting NCT06199700 - Esketamine for the Treatment of Rett Syndrome Early Phase 1
Completed NCT03941444 - ANAVEX2-73 Study in Patients With Rett Syndrome Phase 3
Recruiting NCT06346106 - The Diagnostic Experience of Male Rett Syndrome